Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome

Table 10 Irritable bowel syndrome quality of life scale total scores of females and males irritable bowel syndrome patients belonging to different irritable bowel syndrome-subtypes

Time after FMT	IBS-D			IBS-C			IBS-M
	Females	Males	P value	Females	Males	P value	Females	Males	P value
2 wk	123.3 ± 98	123.7 ± 25.5	0.8	120.5 ± 23.1	102.4 ± 28.0	0.06	123.1 ± 24.6	131.5 ± 13.0	0.4
1 mo	131.3 ± 20.8	129.6 ± 28.2	0.9	121.9 ± 24.4	111.4 ± 29.1	01	125.4 ± 25.2	130.5 ± 11.3	0.8
3 mo	136.4 ± 16.6	134.5 ± 22.7	0.9	128.7 ± 24.4	129.1 ± 31.3	0.6	129.5 ± 28.6	124.8 ± 22.0	0.5

Data are mean ± SD values. IBS-D: Irritable bowel syndrome with diarrhoea-predominant symptom; IBS-C: Irritable bowel syndrome with constipation-predominant symptom; IBS-M: Irritable bowel syndrome with mixed diarrhoea and constipation; FMT: Faecal microbiota transplantation.